Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CAO Craig Gracey sold 2,083 shares of the company’s stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83. Following the completion of the sale, the chief accounting officer directly owned 5,025 shares in the company, valued at $95,525.25. This trade represents a 29.31% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Craig Gracey also recently made the following trade(s):
- On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
- On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.
Omada Health Trading Up 10.5%
Shares of NASDAQ OMDA traded up $1.99 during trading on Friday, reaching $20.89. The company had a trading volume of 3,310,497 shares, compared to its average volume of 946,807. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The stock has a market capitalization of $1.24 billion and a PE ratio of -77.37. The stock has a 50-day moving average price of $16.51 and a two-hundred day moving average price of $14.85.
Institutional Trading of Omada Health
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Quarry LP purchased a new position in Omada Health in the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. purchased a new position in shares of Omada Health in the 4th quarter valued at $32,000. Raymond James Financial Inc. acquired a new position in shares of Omada Health during the 2nd quarter valued at $32,000. Inlight Wealth Management LLC acquired a new stake in Omada Health in the 4th quarter valued at $45,000. Finally, Strs Ohio raised its position in Omada Health by 151.0% in the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock valued at $67,000 after purchasing an additional 2,567 shares during the period.
Analyst Ratings Changes
A number of analysts recently issued reports on the stock. Barclays raised their target price on shares of Omada Health from $18.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. The Goldman Sachs Group reissued a “buy” rating on shares of Omada Health in a research note on Friday, May 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Omada Health in a report on Thursday, June 4th. Citigroup reissued an “outperform” rating on shares of Omada Health in a research note on Friday, May 8th. Finally, Citizens Jmp increased their price objective on shares of Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Omada Health presently has a consensus rating of “Moderate Buy” and an average target price of $22.91.
Check Out Our Latest Research Report on OMDA
About Omada Health
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Further Reading
- Five stocks we like better than Omada Health
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
